Nightingale
Research Trials
Now
Now
Recruiting
Heart Failure with Obesity Study
Adelaide SA | Frankston VIC
A research study looking at a new medication for people with Heart Failure and Obesity.
- Age > 18 years
- BMI ≥ 30kg/m2
- Heart function > 40% (tested within 12 months or at screening visit)
- Weekly self-injection
- Not taking Ozempic/Mounjaro for 90 days prior to screening
- Can be diabetic or non-diabetic
Heart Disease, Diabetes and High Blood Pressure Study
Adelaide SA | Frankston VIC
A study to test a new medication in combination with Empagliflozin (a currently available medication) in people with Type 2 Diabetes, high blood pressure and cardiovascular disease.
- Age > 18 years
- History of heart attack, stroke or vascular disease AND high blood pressure
- One additional risk factor for developing heart failure (assessed at screening)
- Diabetic or non-diabetic
- Oral tablet daily
Symptomatic Heart Failure Study
Frankston VIC
Effect of a new medication in combination with Empagliflozin (medication available currently) in patients with HF and EF>40%.
- Age > 18 years
- Elevated heart failure bloods (tested at screening visit)
- Taking diuretic medication
- Oral tablet daily
Upcoming Trials
▼
There are currently no trials in this category.
Ongoing Trials
(Enrolment Closed)
▼
Adelaide SA | Frankston VIC
Effect of a new medication on patients with established CVD and/or CKD.
- Age > 50 years
- BMI > 25 kg/m²
Completed Trials
▼
There are currently no trials in this category.